Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 USD | -1.00% | -5.71% | -10.54% |
Business Summary
Number of employees: 159
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Allogeneic Cell Therapies
100.0
%
| 5 | 100.0 % | 2 | 100.0 % | -57.01% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 5 | 100.0 % | 2 | 100.0 % | -57.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | Dec. 03 | |
Douglas Carr
DFI | Director of Finance/CFO | - | 18-09-30 |
Kenneth J. Dow
CMP | Compliance Officer | - | - |
Gregory Russotti
CTO | Chief Tech/Sci/R&D Officer | 57 | 19-12-31 |
Adrienne Farid
COO | Chief Operating Officer | 62 | 21-03-31 |
Hyam Levitsky
CTO | Chief Tech/Sci/R&D Officer | 66 | 19-04-30 |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 22-09-30 |
Joseph Jimenez
CHM | Chairman | 64 | 19-07-31 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 21-01-31 |
Daphne Quimi
BRD | Director/Board Member | 58 | 22-09-30 |
Alessandro Riva
BRD | Director/Board Member | 63 | 21-04-30 |
Carlo Rizzuto
BRD | Director/Board Member | 53 | 18-02-28 |
Director/Board Member | 55 | 21-04-30 | |
Chief Executive Officer | - | Dec. 03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,847,375 | 58,959,963 ( 71.17 %) | 0 | 71.17 % |
Company contact information
Century Therapeutics, Inc.
38th Street, 25 North 11th Floor
19104, Philadelphia
+
http://www.centurytx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.54% | 247M | |
+44.48% | 55.07B | |
+43.68% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- IPSC Stock
- Company Century Therapeutics, Inc.